Compugen Stock

Compugen Asset Growth

Delisted·Jun 15, 2026

The Year-over-Year Total Asset Growth of Compugen (CGEN) as of Aug 3, 2026 is 36.42 %. In the previous year, Year-over-Year Total Asset Growth was -5.22 % — a change of -797.06% (higher).

Asset Growth

36.42 %

YoY

-797.06%

Last updated:

Year-over-Year Total Asset Growth of Compugen is 2026 36.42 % . Year-over-Year Total Asset Growth of Compugen was 2025 -5.22 % . It decreases by -797.06% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Year-over-Year Total Asset Growth of Compugen is 36.42 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year Total Asset Growth Compugen since 2006 – with annual values, charts, and detailed analysis.

Asset growth measures the percentage change in total assets. Rapid asset growth may indicate expansion but can also correlate with lower future returns.

To evaluate Year-over-Year Total Asset Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Total Asset Growth.

Year-over-Year Total Asset Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Total Asset Growth's Compugen historically and in real time.

Access this data via the Eulerpool API

Growth — Compugen

All Key Metrics — Compugen